Patrik graduated from the Business University of St. Gallen and completed his Ph.D thesis (“Assessment and valuation of high growth companies”) at the Swiss Federal Institute of Technology, EPFL Lausanne. Prior to forming Venture Valuation, Patrik was CFO of a logistic company and worked for several international corporations including LeCroy (Geneva, New York), Hans Merensky Holding (South Africa) and Swatch Group – EM Microelectronic (Marin). Patrik was a board member and one of the original founders of Ineo, a holding company of the Swiss dental implant VC-backed firm Thommen Medical. He is also the Chairman of Ophthalmopharma, a Swiss based biotech ophthalmology company, where he successfully out-licensed a portfolio of 4 products. Patrik’s articles have been published in a number of scientific journals including “Nature Biotechnology”, “Chimia” and other business publications (“Starting a Business in the Life Sciences: From Idea to MARKET” and “Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies”). He has also lectured at Seoul National University, South Korea, EPFL Lausanne, University of St. Gallen and gives regular workshops on valuation.   Patrik graduated from the Business University of St. Gallen and completed his Ph.D thesis (“Assessment and valuation of high growth companies”) at the Swiss Federal Institute of Technology, EPFL Lausanne. Prior to forming Venture Valuation, Patrik was CFO of a logistic company and worked for several international corporations including LeCroy (Geneva, New York), Hans Merensky Holding (South Africa) and Swatch Group – EM Microelectronic (Marin). Patrik was a board member and one of the original founders of Ineo, a holding company of the Swiss dental implant VC-backed firm Thommen Medical. He is also the Chairman of Ophthalmopharma, a Swiss based biotech ophthalmology company, where he successfully out-licensed a portfolio of 4 products. Patrik’s articles have been published in a number of scientific journals including “Nature Biotechnology”, “Chimia” and other business publications (“Starting a Business in the Life Sciences: From Idea to MARKET” and “Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies”). He has also lectured at Seoul National University, South Korea, EPFL Lausanne, University of St. Gallen and gives regular workshops on valuation.  

Biopharmaceutical Science, Business Management